RAS Inhibitor, Metformin Use Does Not Affect SGLT2 Inhibitor Kidney Outcomes Endocrinology Advisor, 22 Jul 2024 Concurrent metformin or renin-angiotensin system (RAS) inhibitor therapy has little effect on sodium-glucose cotransporter-2 (SGL…